Adrenal suppression by oral high-dose medroxyprogesterone acetate in breast cancer patients
- 1 February 1984
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 12 (2) , 83-86
- https://doi.org/10.1007/bf00254594
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effect of medroxyprogesterone acetate on serum levels of LH, FSH, cortisol, and estrone in patients with endometrial carcinomaArchiv für Gynäkologie, 1981
- Comparative pharmacokinetics of medroxyprogesterone acetate administered by oral and intramuscular routesCancer Chemotherapy and Pharmacology, 1980
- Plasma 11-deoxycortisol, androstenedione, testosterone and ACTH in comparison with the urinary excretion of tetrahydro-11-deoxycortisol as indices of the pituitary-adrenal response to oral metyraponeActa Endocrinologica, 1980
- High-Dose Medroxyprogesterone Acetate (MPA) Treatment in Advanced Breast Cancer. A ReviewTumori Journal, 1979
- High-dose medroxyprogesterone acetate in breast cancer resistant to endocrine and cytotoxic therapyCancer Chemotherapy and Pharmacology, 1979
- The Hormonal Activity of the Postmenopausal OvaryJournal of Clinical Endocrinology & Metabolism, 1976
- Pituitary-Adrenal Function in Ten Patients Receiving Medroxyprogesterone Acetate for True Precocious PubertyJournal of Clinical Endocrinology & Metabolism, 1970
- Inhibition of Adrenal Protein Synthesis by Steroidsin Vitro1Endocrinology, 1967
- Identification of a 6,21-Dihydroxlyated Metabolite of Medroxyprogesterone Acetate in Human UrineJournal of Clinical Endocrinology & Metabolism, 1962
- ISOLATION AND IDENTIFICATION OF 6β, 17α, 21-TRIHYDROXY-6α-METHYL-Δ4-PREGNENE-3,20-DIONE (21-ACETATE) FROM THE URINE OF HUMAN SUBJECTS TREATED WITH 6α-METHYL-17α-ACETOXYPROGESTERONEJournal of Endocrinology, 1962